PER 5.71% 9.9¢ percheron therapeutics limited

Pfizer hits brakes on DMD gene therapy, page-4

  1. 35,751 Posts.
    lightbulb Created with Sketch. 554
    "FDA will make both Pfizer and Sarepta jump through some very expensive and time consuming hoops to prove GT safety and efficacy"

    Huh just another @Uboy throw away line ? ... given FDA have awarded Pfizer FTD 6 months ago ?

    Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy | pfpfizeruscom

    Anything that has to go back though the FDA takes a lot of time, and people whinge about the 30 days for ANP's minutes ......

    FDA might have over 10.000 employees but that's nothing against the number of clinical trials underway - these things always take time.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.